Tetrapeptide-21
960608-17-7
99%
shenzhen
Customizable
5MG 10MG 20MG 30MG 60MG---1G 100G 1KG
2035-06-26
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceTetrapeptide-21 is a tetrapeptide derived from the skin itself. It has a unique structure and can promote the synthesis of extracellular matrix, thereby reducing various wrinkles and improving skin aging. Compared with the very popular base peptide (Matrixyl) on the market, the effect of tetrapeptide-21 is more prominent.Research & Reference Note
Tetrapeptide-21 is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
Tetrapeptide-21
Other Name:(4S)-4-[(2-aminoacetyl)amino]-5-[[(2S)-6-amino-1-(carboxymethylamino)-1-oxohexan-2-yl]amino]-5-oxopentanoic acid;Tetrapeptide-21;Glycine, glycyl-L-α-glutamyl-L-lysyl-;960608-17-7 Tetrapeptide-21;Tetrapeptide-21 USP/EP/BP;Tetrapeptide-21 (Reference:TEGO pep4-17)
CAS No.:960608-17-7
Molecular Formula:C15H27N5O7
InChIKeys:CUVSTAMIHSSVKL-UWVGGRQHSA-N
Molecular Weight:389.4
EC Number:000-000-0
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.336±0.06 g/cm3(Predicted)
Boiling Point:896.1±65.0 °C(Predicted)
PKA:3.29±0.10(Predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide
-
Location:
No.2888 Sichuan Qingbaijiang Avenue
-
Average lead Time:
7
-
Year of Establishment:
2025
-
Certifications:
contact,contract
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product